Home › Funds › Redmile Group, LLC › DBVT
Redmile Group, LLC position in DBVT
DBV TECHNOLOGIES S A · Health Care
Redmile Group, LLC reported holding 410,440 shares of DBVT (DBV TECHNOLOGIES S A) in its Q2 2026 13F filing — a position valued at US$6.7M, representing 0.45% of its reported portfolio and ranking #31 among its reported holdings. Redmile Group, LLC has disclosed DBVT holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Redmile Group, LLC's DBVT position evolved
Redmile Group, LLC first disclosed a stake in DBVT in Q4 2025 at 549,840 shares (US$10.5M). Across 3 filings, Redmile Group, LLC increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 410,440 shares valued at US$6.7M — a reduction of -80,900 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 549.84K | $10.54M | New |
| Q1 2026 | 491.34K | $10.26M | Reduce |
| Q2 2026 | 410.44K | $6.73M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About DBVT and 13F data
DBVT (DBV TECHNOLOGIES S A) is a Health Care company. 57 other funds we track also report a position in DBVT — the largest reported positions include MPM BioImpact LLC (US$60.1M), Siren, L.L.C. (US$30.5M), Vivo Capital, LLC (US$30.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding DBVT
- MPM BioImpact LLC 3.67M sh · $60.13M · Q2 2026
- Siren, L.L.C. 1.86M sh · $30.46M · Q2 2026
- Vivo Capital, LLC 1.84M sh · $30.25M · Q2 2026
- PERCEPTIVE ADVISORS LLC 1.65M sh · $27.11M · Q2 2026
- Logos Global Management LP 915.00K sh · $15.01M · Q2 2026
- Patient Square Capital LP 909.47K sh · $14.92M · Q2 2026
- Octagon Capital Advisors LP 574.20K sh · $9.42M · Q2 2026
- Elmind Capital, LP 265.00K sh · $4.35M · Q2 2026
- Ishara Investments LP 184.50K sh · $3.03M · Q2 2026
- Yiheng Capital Management, L.P. 170.14K sh · $2.79M · Q2 2026
- GREAT POINT PARTNERS LLC 156.91K sh · $2.57M · Q2 2026
More on Redmile Group, LLC
FAQ
How long has Redmile Group, LLC held DBVT?
Redmile Group, LLC has disclosed DBVT holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
What is Redmile Group, LLC's current position in DBVT?
As of Q2 2026, Redmile Group, LLC holds 410.44K shares of DBVT (DBV TECHNOLOGIES S A), valued at $6.73M, representing 0.45% of its reported portfolio and ranking #31.
Has Redmile Group, LLC been buying or selling DBVT?
In the latest 13F filing (Q2 2026), Redmile Group, LLC reduced its position in DBVT.
Which other funds hold DBVT?
Other major institutional holders of DBVT include MPM BioImpact LLC, Siren, L.L.C., Vivo Capital, LLC, among 57 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.